These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 30149394)

  • 1. Skeletal Muscle Loss during Neoadjuvant Chemotherapy Is an Independent Risk Factor for Postoperative Infectious Complications in Patients with Advanced Esophageal Cancer.
    Motoori M; Fujitani K; Sugimura K; Miyata H; Nakatsuka R; Nishizawa Y; Komatsu H; Miyazaki S; Komori T; Kashiwazaki M; Iwase K; Yano M
    Oncology; 2018; 95(5):281-287. PubMed ID: 30149394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact on postoperative complications of changes in skeletal muscle mass during neoadjuvant chemotherapy for gastro-oesophageal cancer.
    den Boer RB; Jones KI; Ash S; van Boxel GI; Gillies RS; O'Donnell T; Ruurda JP; Sgromo B; Silva MA; Maynard ND
    BJS Open; 2020 Oct; 4(5):847-854. PubMed ID: 32841538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of measurement of skeletal muscle mass on clinical outcomes in patients with esophageal cancer undergoing esophagectomy after neoadjuvant chemotherapy.
    Ishida T; Makino T; Yamasaki M; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Motoori M; Kimura Y; Nakajima K; Mori M; Doki Y
    Surgery; 2019 Dec; 166(6):1041-1047. PubMed ID: 31607486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study.
    Järvinen T; Ilonen I; Kauppi J; Salo J; Räsänen J
    World J Surg Oncol; 2018 Feb; 16(1):27. PubMed ID: 29433514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy.
    Panje CM; Höng L; Hayoz S; Baracos VE; Herrmann E; Garcia Schüler H; Meier UR; Henke G; Schacher S; Hawle H; Gérard MA; Ruhstaller T; Plasswilm L;
    Radiat Oncol; 2019 Sep; 14(1):166. PubMed ID: 31511012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal muscle loss is an independent negative prognostic factor in patients with advanced lower rectal cancer treated with neoadjuvant chemoradiotherapy.
    Takeda Y; Akiyoshi T; Matsueda K; Fukuoka H; Ogura A; Miki H; Hiyoshi Y; Nagasaki T; Konishi T; Fujimoto Y; Fukunaga Y; Ueno M
    PLoS One; 2018; 13(4):e0195406. PubMed ID: 29630652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Assessment of Sarcopenia and Changes in Body Composition During Neoadjuvant Chemotherapy for Esophageal Cancer.
    Miyata H; Sugimura K; Motoori M; Fujiwara Y; Omori T; Yanagimoto Y; Ohue M; Yasui M; Miyoshi N; Tomokuni A; Akita H; Kobayashi S; Takahashi H; Yano M
    Anticancer Res; 2017 Jun; 37(6):3053-3059. PubMed ID: 28551644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Skeletal Muscle Loss and Sarcopenia on Outcomes of Locally Advanced Esophageal Cancer during Neoadjuvant Chemoradiation.
    Xiao X; Fang PH; Zhou JF; Li XK; Shang QX; Yang YS; Luan SY; Chen LQ; Yuan Y
    Ann Surg Oncol; 2024 Jun; 31(6):3819-3829. PubMed ID: 38245646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Skeletal Muscle Mass During Neoadjuvant Chemoradiotherapy Predicts Postoperative Mortality in Esophageal Cancer Surgery.
    Reisinger KW; Bosmans JW; Uittenbogaart M; Alsoumali A; Poeze M; Sosef MN; Derikx JP
    Ann Surg Oncol; 2015 Dec; 22(13):4445-52. PubMed ID: 25893413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in body composition secondary to neoadjuvant chemotherapy for advanced esophageal cancer are related to the occurrence of postoperative complications after esophagectomy.
    Ida S; Watanabe M; Karashima R; Imamura Y; Ishimoto T; Baba Y; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Baba H
    Ann Surg Oncol; 2014 Oct; 21(11):3675-9. PubMed ID: 24793436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal muscle mass as a predictor of the response to neo-adjuvant chemotherapy in locally advanced esophageal cancer.
    Ota T; Ishikawa T; Endo Y; Matsumura S; Yoshida J; Yasuda T; Okayama T; Inoue K; Dohi O; Yoshida N; Sakamoto N; Kamada K; Uchiyama K; Takagi T; Konishi H; Konishi H; Shiozaki A; Fujiwara H; Kishimoto M; Naito Y; Itoh Y
    Med Oncol; 2019 Jan; 36(2):15. PubMed ID: 30600347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative sarcopenia is a predictor of postoperative pulmonary complications in esophageal cancer following esophagectomy: A retrospective cohort study.
    Makiura D; Ono R; Inoue J; Kashiwa M; Oshikiri T; Nakamura T; Kakeji Y; Sakai Y; Miura Y
    J Geriatr Oncol; 2016 Nov; 7(6):430-436. PubMed ID: 27452909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal Muscle Loss After Esophagectomy Is an Independent Risk Factor for Patients with Esophageal Cancer.
    Nakashima Y; Saeki H; Hu Q; Tsuda Y; Zaitsu Y; Hisamatsu Y; Ando K; Kimura Y; Oki E; Mori M
    Ann Surg Oncol; 2020 Feb; 27(2):492-498. PubMed ID: 31549319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcopenia is a Predictor of Postoperative Respiratory Complications in Patients with Esophageal Cancer.
    Ida S; Watanabe M; Yoshida N; Baba Y; Umezaki N; Harada K; Karashima R; Imamura Y; Iwagami S; Baba H
    Ann Surg Oncol; 2015 Dec; 22(13):4432-7. PubMed ID: 25862583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal muscle loss in the postoperative acute phase after esophageal cancer surgery as a new prognostic factor.
    Maeda N; Shirakawa Y; Tanabe S; Sakurama K; Noma K; Fujiwara T
    World J Surg Oncol; 2020 Jun; 18(1):143. PubMed ID: 32591002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia: Prevalence, and Impact on Operative and Oncologic Outcomes in the Multimodal Management of Locally Advanced Esophageal Cancer.
    Elliott JA; Doyle SL; Murphy CF; King S; Guinan EM; Beddy P; Ravi N; Reynolds JV
    Ann Surg; 2017 Nov; 266(5):822-830. PubMed ID: 28796017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboembolic events before esophagectomy for esophageal cancer do not result in worse outcomes.
    Teman NR; Silski L; Zhao L; Kober M; Urba SC; Orringer MB; Chang AC; Lin J; Reddy RM
    Ann Thorac Surg; 2012 Oct; 94(4):1118-24; discussion 1124-5. PubMed ID: 22858275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients triaged to neoadjuvant chemotherapy have higher rates of sarcopenia: An opportunity for prehabilitation.
    Fadadu PP; Polen-De CL; McGree ME; Weaver AL; Moynagh MR; Takahashi N; Langstraat CL; Cliby WA; Kumar A
    Gynecol Oncol; 2021 Jan; 160(1):40-44. PubMed ID: 33109391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Significance of Skeletal Muscle Loss During Early Postoperative Period in Elderly Patients with Esophageal Cancer.
    Takahashi K; Watanabe M; Kozuki R; Toihata T; Okamura A; Imamura Y; Mine S; Ishizuka N
    Ann Surg Oncol; 2019 Oct; 26(11):3727-3735. PubMed ID: 31313039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of neoadjuvant chemotherapy and chemoradiotherapy on postoperative cardiopulmonary complications in patients with esophageal cancer.
    Zhang Z; Zhang H
    Dis Esophagus; 2017 Apr; 30(4):1-7. PubMed ID: 28375486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.